Chromium Treatment Has No Effect in Patients With Type 2 Diabetes in a Western Population

Authors:

Abstract
OBJECTIVE—Chromium treatment has been reported to improve glycemic control in patients with type 2 diabetes. However, concern exists about the possible toxic effects of chromium picolinate. The aim of this study was to determine the effect of chromium treatment in the form of chromium yeast on glycemic control in a Western population of patients with type 2 diabetes who were being treated with oral hypoglycemic agents.

This publication has 29 references indexed in Scilit: